CCM Investment Advisers LLC lifted its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 23.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 31,137 shares of the semiconductor company’s stock after buying an additional 6,009 shares during the period. CCM Investment Advisers LLC’s holdings in Synopsys were worth $12,345,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Sankala Group LLC bought a new position in Synopsys in the fourth quarter valued at approximately $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Synopsys in the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd bought a new position in Synopsys in the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new stake in Synopsys in the 4th quarter valued at $32,000. Finally, Phillip James Consulting Co. acquired a new stake in shares of Synopsys during the fourth quarter worth $36,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. Benchmark assumed coverage on Synopsys in a report on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective for the company. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Rosenblatt Securities upped their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Finally, BNP Paribas Exane lifted their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $570.06.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Synopsys Stock Performance
Shares of SNPS stock opened at $372.33 on Friday. Synopsys, Inc. has a one year low of $366.00 and a one year high of $646.28. The firm has a 50-day moving average of $446.60 and a 200-day moving average of $451.11. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The company has a market cap of $71.29 billion, a P/E ratio of 86.19, a P/E/G ratio of 2.20 and a beta of 1.22.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the firm posted $3.67 EPS. The business’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
